Barriers, adoption, technology, impact and benefits of risk based monitoring
Abstract
Keywords
Full Text:
PDFReferences
US FDA, Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring Guidance, Draft. 2011. http://www.fda.gov/downloads/Drugs /.../ Guidances/UCM269919.pdf. Last Accessed on 22 Dec 2015
Dana-Farber/Harvard Cancer Center: Guidance on Investigator Interactions with Monitors, 29 June 2012. http://www.dfhcc.harvard.edu/ crs-resources/oversight/policy_and_guidance/auditing_sops_and_guidances/Guidance_on_Responding_to_Audit_Findings.pdf. Last Accessed on 22 Dec 2015
Ken Getz. Low Hanging Fruit in the Fight Against Inefficiency, Applied Clinical Trials Online. 2011. http://www.appliedclinicaltrialsonline.com/low-hanging-fruit-fight-against-inefficiency. Last Accessed on 22 Dec 2015
Tantsyura. Risk-based Source Data Verification Approaches: Pros and Cons. DIA J. 2010;44:45-756.
PhRMA White Paper on Acceptable Approaches for Clinical Trial Monitoring. 2009.
Baigent. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008;5:49-55.
Guidance for Industry: Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring, U.S. Department of Health and Human Services. 2011:8.
Reflection Paper on Risk-Based Quality Management in Clinical Trials, European Medicines Agency. 2011. EMA/INS/GCP/394194/2011.
Guidance for Industry Oversight of Clinical Investigations: A Risk Based Approach to Monitoring (Draft Guidance), U.S. Food & Drug Administration. 2011. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM269919.pdf. Last Accessed on 22 Dec 2015.
Risk-Adapted Approaches to the Management of Clinical Trials of Investigational Medicinal Products, Medicines and Healthcare Products Regulatory Agency. 2011.
Guidance for Industry Oversight of Clinical Investigations: A Risk Based Approach to Monitoring (Draft Guidance), U.S. Food & Drug Administration. 2011.
Monitoring the Quality of Conduct of Clinical Trials: A Survey of Current Practices, Clinical Trials. 2011;8,(3):342-9. http://ctj.sagepub.com/ content/8/3/342. Last Accessed on 22 Dec 2015.
Guidance Webinar Video, Transcript from FDA Webinar Session. 2012.
Guidance on Risk-Proportionate Approaches to the Management and Monitoring of Clinical Trials, Medicines and Healthcare Products Regulatory Agency. 2011.
Guidance for Industry Oversight of Clinical Investigations: A Risk Based Approach to Monitoring (Draft Guidance), U.S. Food & Drug Administration. 2011.
Malcolm Frank, Don’t Get SMACked: How Social, Mobile, Analytics and Cloud Technologies are Reshaping the Enterprise, Cognizant Technology Solutions. 2012.
Outlook 2013, Tufts Center for the Study of Drug Development. 2013.
Pharma Annual Membership Survey, Pharmaceutical Research and Manufacturers of America. 2001-2013.
Innovation in the Biopharmaceutical Pipeline: A Multidimensional View. Analysis Group.
Guidance for Industry: Oversight of clinical investigations - A risk-based approach to monitoring. Food and Drug Administration. August 2013. Available at: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformati. Last Accessed on 22 Dec 2015.
Reflection paper on risk based quality management in clinical trials. European Medicines Agency. November 2013. Available at: file:///C:/ Users/Customer/Downloads/EMA%20Reflection%20paper%20risk%20based%20QM%20in%20CT_2013%20(4).pdf. Last Accessed on 22 Dec 2015.
Taking the Risk: An Examination of Current Organizational Approaches and e-Data Sources Driving Risk-Based Monitoring Programs. Risk Based Monitoring Full Report. Metrics Champion Consortium. 2014.
http://www.datatrial.com/information-center/white-papers/risk-based-monitoring -how- use- enhanced-collaboration -data- review-and, www.datatrial.com/ information-center/white-papers. Last Accessed on 22 Dec 2015
knowledgent.com/wp-content/uploads/2014/07/ Risk-Based- Monitoring_ Knowledgent.pdf. Last Accessed on 22 Dec 2015.